Suspected opioid overdose deaths are surging during the COVID-19 pandemic, increasing by more than 40% in May and continuing to rise. The short-term emergency authorizations for audio-only buprenorphine treatment during COVID-19 have helped us reach people previously unable to access treatment, and these changes should be made permanent.